Stay updated on AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial page.

Latest updates to the AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a new revision tag, updating from v3.6.5 to v3.6.6. This reflects a small metadata update to the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows a newer revision tag (v3.6.5) replacing the previous v3.6.4. This indicates a deployment or version update rather than changes to the study data.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, reflecting a minor page version upgrade without altering study information or navigation.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page’s revision label updated from v3.6.0 to v3.6.3. This is a UI/versioning update and does not alter the study details.SummaryDifference0.0%

- Check80 days agoChange DetectedThe study page now displays a recruitment status indicating no further enrollment and adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading is standardized and the page revision updated to v3.6.0.SummaryDifference0.5%

- Check88 days agoChange DetectedThe page shows a new revision number (v3.5.5) replacing the previous v3.5.4, indicating a small update to the page's version or backend system.SummaryDifference0.1%

Stay in the know with updates to AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial page.